Skip to content

Clinical trials

Phase 2 Small Cell Lung Carcinoma trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Small Cell Lung Carcinoma Phase: Phase 2 Country / region: Germany Clear all

23 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20082
20111
20121
20132
20144
20151
20161
20171
20212
20221
20232
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Terminated5
Recruiting4
Active, not recruiting3
Unknown status2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Amgen2
AIO-Studien-gGmbH1
AbbVie1
Bayer1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Charite University, Berlin, Germany1
Clovis Oncology, Inc.1
Daiichi Sankyo1
ETOP IBCSG Partners Foundation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Small Cell Lung Carcinoma23
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms2
Brain Neoplasms1
Meningioma1
Pituitary Neoplasms1

Trials

Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.